5-Bromo-2-methoxypyrimidin-4-amine

Catalog No. :
ACLGQV916
CAS No. :
148214-56-6
Molecular Formula :
C5H6BrN3O
Molecular Weight :
204.03

IUPAC Name:5-bromo-2-methoxypyrimidin-4-amine

5-Bromo-2-methoxypyrimidin-4-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$181.00Login to see priceIn stockInquiry
25g95%$633.00Login to see priceIn stockInquiry
100g95%$2131.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-2-methoxypyrimidin-4-amine
IUPAC Name5-bromo-2-methoxypyrimidin-4-amine
MDL No.MFCD09953511
Molecular FormulaC5H6BrN3O
Molecular Weight204.03
SMILESBrC1=CN=C(N=C1N)OC
InChI KeyOFKKQTPLZJNGOF-UHFFFAOYSA-N
SynonymDS-0318 | DTXSID70672016 | FS-2742 | SY065591 | 5-bromo-2-methoxypyrimidin-4-amine | 5-BROMO-2-METHOXYPYRIMIDIN-4-YLAMINE | W-205676 | AMY082 | FT-0649178 | 4-Pyrimidinamine, 5-bromo-2-methoxy- | OFKKQTPLZJNGOF-UHFFFAOYSA-N | SCHEMBL2724076 | CS-0018943 |
CAS No.148214-56-6
PubChem CID45789781

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACLGQV916 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACRTPX567 route compound structure diagram
    ACRTPX567205672-25-9 In Stock
  4. Then
  5. ACLGQV916 route product structure diagram
    ACLGQV916148214-56-6 In Stock
Inquiry

2. ACLGQV916 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACRTPX567 route compound structure diagram
    ACRTPX567205672-25-9 In Stock
  4. Then
  5. ACLGQV916 route product structure diagram
    ACLGQV916148214-56-6 In Stock
Inquiry

Comments (0)